Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: A capsule containing 90 µg of menaquinone daily for 8 weeks. Intervention 2: control group: A capsule containing avesil daily for 8 weeks.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Suffering from polycystic ovary syndrome based on Rotterdam criteria; Age between 18 to 40
Exclusion criteria
Exclusion criteria: Unwillingness to participate Any disease or physiological changes that requires special treatment Pregnancy or lactation Using antidiabetic, antihypertensives, antihyperlipidemics or anticoagulant treatment Using metformin 2 months before entering the study and during the intervention; Acute or chronic inflammation Being smoker or/and alcoholic. Using drugs effective on bone metabolism Any current diet or supplement treatment Using oral contraceptives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score in BECK questionnaire. Timepoint: Before and after the intervention. Method of measurement: BECK depression questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum vitamin K level. Timepoint: Before and after the intervention. Method of measurement: ELISA kit.;Fasting Blood Sugar. Timepoint: Before and after intervention. Method of measurement: auto analyser. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFiroozeh Tarkesh
Shiraz University of Medical Sciences
Outcome results
None listed